School of Medicine
Showing 1-4 of 4 Results
-
Lei (Stanley) Qi
Associate Professor of Bioengineering
On Leave from 01/01/2023 To 06/30/2023BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is one major contributor to the development of CRISPR technology for genome engineering. His lab developed the first nuclease-deactivated Cas9 (dCas9) for gene targeting and regulation in cells. His lab invents a series of CRISPR tools, including CRISPRi and CRISPRa for targeted gene regulation, epigenome editing, LiveFISH for live cell imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a miniature CRISPR for gene therapy, hyperCas12a for multigene engineering, and CRISPR antivirals for treating SARS-CoV-2. His lab is broadly interested in mammalian synthetic biology, epigenome engineering, immune cell engineering, directed evolution, and novel gene therapy. They also actively investigates the functional role of human noncoding genome. Dr. Qi obtained B.S. in Physics and Math from Tsinghua University, Ph.D. in Bioengineering from the University of California, Berkeley, and was a UCSF Systems Biology Fellow. He joined the faculty at Stanford University in 2014.
-
Thomas Quertermous, MD
William G. Irwin Professor of Cardiovascular Medicine
Current Research and Scholarly InterestsUnderstanding genetic basis of cardiovascular function and disease.
